TABLE 2.

Differences in SSCP patterns between plasma and PBMC 5′ UTRs according to the contamination mode in liver transplant and immunocompetent patients

Patient group	Prevalence (%)
Transplant (P = 0.04)
Unknown route	4/13 (31)
Intravenous drug use	2/2 (100)
Multiple transfusion	11/14 (79)
Single transfusion	4/9 (44)
Total	21/38 (55)
Immunocompetent (P = 0.001)
Unknown route	3/16 (19)
Intravenous drug use	14/29 (48)
Multiple transfusion	4/6 (67)
Single transfusion	1/20 (5)
Total	22/71 (31)
All patients	43/109 (39)